Sentinel Node Evaluation in Prostate Cancer{A figure is presented}

EAU-EBU Update Series

Volumn 5, Issue 6, 2007, Pages 223-231

  Meinhardt, Willem ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Lymph nodes; Lymphadenectomy; Prostate cancer; Radioguided surgery; Sentinel node

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN; TECHNETIUM 99M; TRACER;

ACCURACY; ADVANCED CANCER; BIOPSY TECHNIQUE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HORMONAL THERAPY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MEDICAL DECISION MAKING; MICROMETASTASIS; NOMOGRAM; NON INVASIVE MEASUREMENT; PATHOLOGICAL ANATOMY; PATIENT SELECTION; PELVIS LYMPH NODE; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RADIOSURGERY; RELIABILITY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TUMOR LOCALIZATION;

EID: 35448950444     PISSN: 18712592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eeus.2007.07.003     Document Type: Review

References (43)

1. Golimbu M., Moralis P., Al-Askari S., and Brown J. Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121 (1979) 617-619
2. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
3. Shackley D.C., Irving S.O., Brough W.A., and O'Reilly P.H. Staging laparoscopic pelvic lymphadenectomy in prostate cancer. BJU Int 83 (1999) 260-264
4. Perrotti M., Gentle D.L., Barada J.H., Wilbur H.J., and Kaufman Jr. R.P. Mini-laparotomy pelvic lymphnode dissection minimises morbidity, hospitalisation and cost of pelvic lymphnode dissection. J Urol 155 (1996) 986-988
5. Heidenreich A., Zoltan V., and von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
6. Burkhard F.C., Bader P., Schneider E., Markwalder R., and Studer U.E. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 42 (2002) 84-92
7. Allaf M.E., et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 3 (2004) 849-854
8. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
9. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 4 (1992) 392-399
10. Morton D.L., Thompson J.F., Essner R., et al. Immediate versus delayed lymphadenectomy in the management of primary melanoma. N Engl J Med 355 (2006) 1307-1317
11. Nieweg O.E., Van Rijk M.C., Valdés Olmos R.A., and Hoefnagel C.A. Sentinel node biopsy and selective lymph node clearance-impact on regional control and survival in breast cancer and melanoma. Eur J Nucl Med Mol Imaging 32 (2005) 631-634
12. Tanis P.J., Lont A.P., Meinhardt W., Valdés Olmos R.A., Nieweg O.E., and Horenblas S. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 168 (2002) 76-80
13. Lont A.P., Gallee M.P., Snijders P., and Horenblas S. Sarcomatoid squamous cell carcinoma of the penis: a clinical and pathological study of 5 cases. J Urol 172 (2004) 932-935
14. Wawroschek F., Vogt H., Weckermann D., Wagner T., and Harzman R. The sentinel lymphnode concept in prostate cancer-first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36 (1999) 595-600
15. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
16. Dhar N.B., Burkhard F.C., and Studer U.E. Role of lymphadenectomy in clinically organ-confined prostate cancer. World J Urol 25 (2007) 39-44
17. Cheng L., Zincke H., Blute M.L., et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
18. Fossa S.D., Lilleby W., Waehre H., et al. Definite radiotherapy of prostate cancer: the possible role of staging lymphadenectomy. Int J Radiat Oncol Biol Phys 57 (2003) 33-41
19. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol 166 (2001) 2185-2188
20. Kattan M.W., Eastham J.A., Stapleton A.M., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
21. Chun F.K.-H., Karakiewicz P.I., Briganti A., et al. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. BJU Int 99 (2007) 794-800
22. Aus G., Nordenskjöld K., Robinson D., Rosell J., and Varenhorst E. Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort. Eur Urol 43 (2003) 627-631
23. Gervasi L.A., Mata J., Easley J.D., et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142 (1989) 332-336
24. Raghavaiah N.V., and Jordan W.R. Prostatic lymphography. J Urol 121 (1979) 178-181
25. Brossner C., Ringhofer H., Hernady T., Kuber W., Madersbacher S., and Pycha A. Lymphatic drainage of prostatic transition and peripheral zones visualised on a three-dimensional workstation. Urology 57 (2001) 389-393
26. Beri A., and Janetschek G. Technology insight: radioguided sentinel node lymph node dissection in staging of prostate cancer. Nat Clin Pract Urol 3 (2006) 602-610
27. Meinhardt W, Valdés Olmos RA, van der Poel H, Bex A, Horenblas S. Laparoscopic sentinel node dissection for prostate carcinoma, technical and anatomical aspects. In preparation.
28. Sherif A., Garske U., de la Torre M., and Thörn M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 50 (2006) 83-91
29. Guiliano A.E., Kirgan D.M., Guenter J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
30. Weckermann D., Dorn R., Holl G., Wagner T., and Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51 (2007) 1549-1558
31. Ghoneim M.A., and Abol-Eneim H. Lymphadenectomy with cystectomy: is it necessary and what is its extent?. Eur Urol 46 (2004) 457-461
32. Brenot-Rossi I., Bastide C., Garcia S., et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 32 (2005) 635-640
33. Weckermann D., Dorn R., Trefz M., et al. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 177 (2007) 916-920
34. Jeschke S, Beri A, Grüll M, et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol. In press. doi:10.1016/j.eururo.2007.03.064.
35. Corvin S., Schilling D., Eichhorn K., et al. Laparoscopic sentinel lymph node dissection - a novel technique for the staging of prostate cancer. Eur Urol 49 (2006) 280-285
36. Burkhard F.C., and Studer U.E. The role of lymphadenectomy in prostate cancer. Urol Oncol 22 (2004) 198-204
37. Heidenreich A., and Ohlman C.H. The role of anatomic extended pelvic lymphadenectomy in men undergoing radical prostatectomy for prostate cancer. EAU Update Series 3 (2005) 98-106
38. Briganti A., Chun F.K., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 (2006) 1006-1013
39. Clark T., Parekh D.J., Cookson M.S., et al. Randomised prospective evaluation of extended versus limited node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-148
40. Garret K.L., McNeal J.E., and Cohen R.J. Intraoperative lymph node staging of prostate cancer: the case against. ANZ J Surg 73 (2003) 263-266
41. Wawroschek F., Wagner T., Hamm M., et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 43 (2003) 132-137
42. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
43. Hacker A., Jeschke S., Leeb K., et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176 (2006) 2014-2018